Results 11 to 20 of about 5,863 (212)

Effectiveness of 5% Topical Imiquimod for Lentigo Maligna Treatment

Acta Dermato-Venereologica, 2019
Lentigo maligna (LM) is treated to prevent progression to lentigo maligna melanoma (LMM). Surgery is the gold standard but an alternative treatment is off-label topical imiquimod.
Darryl C.K.S. Tio, Catherine van Montfrans, Claire G.H. Ruijter, Rick Hoekzema, Marcel W. Bekkenk   +4 more
doaj   +2 more sources

Atypical lentigo maligna melanoma of the chin: A case report [PDF]

JAAD Case Reports
Sabrina Ghalili, MD, Doris Day, MD, Jonas A. Adalsteinsson, MD, PhD, Peter Taub, MD, MS, David S. Lee, MD, Jesse M. Lewin, MD   +5 more
doaj   +2 more sources

Clinical, Dermoscopic, and Histopathologic Aspects of Amelanotic Lentigo Maligna Melanoma [PDF]

Dermatology Practical & Conceptual, 2021
Catalin Mihai Popescu, Corina Barna, Alexandru Metea, Razvan Theodor Andrei, Mona Taroi   +4 more
doaj   +2 more sources

Lentigo Maligna Melanoma

Journal of Cutaneous Medicine and Surgery
Puckett Y, Geist R, Chen CSJ.
europepmc   +4 more sources

Lentigo maligna melanoma mapping using reflectance confocal microscopy correlates with staged excision: A prospective study. [PDF]

J Am Acad Dermatol, 2023
Navarrete-Dechent C, Cordova M, Aleissa S, Liopyris K, Dusza SW, Kose K, Busam KJ, Hollman T, Lezcano C, Pulitzer M, Chen CJ, Lee EH, Rossi AM, Nehal KS.   +13 more
europepmc   +2 more sources

Sub-Ultraviolet Light Dermoscopy for Surgical Margin Definition in Lentigo Maligna Melanoma [PDF]

Dermatology Practical & Conceptual
Itziar Muelas Rives, Laura Bernal Masferrer, Beatriz Clemente Hernández, Leticia Ollero Domenche, Maria Carmen Gómez Mateo, Marcial Álvarez Salafranca   +5 more
doaj   +2 more sources

Series of Fourteen Cases of Topical Imiquimod 5% in Lentigo Maligna: Treatment Modalities and Clues for Detecting Recurrences

Actas Dermo-Sifiliográficas, 2022
Topical imiquimod has been used off-label as monotherapy or adjuvant treatment for lentigo maligna. Our aim is to describe treatment modalities, clinical outcomes, and management of recurrence in patients receiving imiquimod for lentigo maligna.Patients ...
I. Poveda-Montoyo, P. Álvarez-Chinchilla, L. Schneller-Pavelescu, P. Hispán-Ocete, J. Bañuls-Roca   +4 more
doaj   +1 more source

Dermoscopy Relevance in Eyelid Lentigo Maligna Melanoma [PDF]

Dermatology Practical & Conceptual
Sabina Vaccari, Alice Nadia Rossi, Matilde Roda, Federico Cassini, Lorenzo Maltoni, Emi Dika   +5 more
doaj   +2 more sources

[Artículo traducido] Serie de 14 casos de tratamiento con imiquimod tópico al 5% en lentigo maligno: modalidades terapéuticas y claves para detectar recidivas

Actas Dermo-Sifiliográficas, 2022
Resumen: Imiquimod tópico ha sido utilizado como monoterapia o tratamiento adyuvante fuera de indicación para el lentigo maligno (LM). Nuestro objetivo es describir las modalidades de tratamiento, los resultados clínicos y el manejo de la recidiva en los
I. Poveda-Montoyo, P. Álvarez-Chinchilla, L. Schneller-Pavelescu, P. Hispán-Ocete, J. Bañuls-Roca   +4 more
doaj   +1 more source

Langerhans Cells as Morphologic Mimickers of Atypical Melanocytes on Reflectance Confocal Microscopy: A Case Report and Review of the Literature

Dermatology Practical & Conceptual, 2021
Pagetoid spread of melanocytes in the epidermis is a common indicator of melanocytic atypia, both histopathologically and with reflectance confocal microscopy (RCM).
Nadiya Chuchvara, Lauren Berger, Catherine Reilly, Amin Maghari, Babar Rao   +4 more
doaj   +1 more source